Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose aspirin for Doppler flow changes in pregnancies with intrauterine growth restriction
IRCT20180227038892N2Phase 3Completed
- Sponsor
- Iran University of Medical Sciences
- Start
- Jun 2022
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of aspirin in intrauterine growth restriction (IUGR) (2 arms), sponsored by Iran University of Medical Sciences. Primary endpoints: Uterine artery Doppler ultrasound findings, Umbilical artery Doppler ultrasound findings and 1 more. Started Jun 2022; status: completed.
02
Drugs
aspirin
03
Conditions
intrauterine growth restriction (IUGR)
Beyond the preview
Go deeper on IRCT20180227038892N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20180227038892N2.